GKB Ophthalmics Complete Financial Statements
GKB • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for GKB Ophthalmics (GKB).
Downloads include all available records across all periods.
For market performance, see the
GKB stock price today
.
Profitability Ratios
Net Profit Margin
6.45%
2025 data
EBITDA Margin
9.68%
2025 data
Operating Margin
10.00%
2025 data
Return on Assets
1.60%
2025 data
Return on Equity
3.57%
2025 data
Balance Sheet Ratios
Current Ratio
16.50
2025 data
Debt to Equity
2.23
2025 data
Equity Ratio
44.80%
2025 data
Asset Turnover
0.25
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+19.2%
Year-over-Year
Net Profit Growth
+300.0%
Year-over-Year
Expense Growth
+3.8%
Year-over-Year
Assets Growth
+8.7%
Year-over-Year
Equity Growth
-12.5%
Year-over-Year
Liabilities Growth
+8.7%
Year-over-Year
Operating Cash Flow Growth
-175.0%
Year-over-Year
Investing Cash Flow Growth
+250.0%
Year-over-Year
Financing Cash Flow Growth
+150.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31 | 31 | 33 | 26 | 22 | 26 | 26 | 21 | 20 | 23 | 24 | 19 | 18 | 18 | 19 | 19 | 19 | 16 | 20 | 16 | 16 | 7 | 17 | 14 | 17 | 13 | 16 | 15 | 16 | 12 |
| Expenses | 27 | 34 | 32 | 26 | 22 | 25 | 27 | 21 | 20 | 21 | 25 | 17 | 16 | 15 | 19 | 18 | 17 | 14 | 18 | 15 | 15 | 8 | 16 | 14 | 15 | 13 | 15 | 14 | 15 | 13 |
| EBITDA | 3 | -3 | 1 | 0 | 1 | 1 | -1 | 0 | 0 | 2 | 0 | 2 | 2 | 3 | 0 | 1 | 2 | 1 | 2 | 1 | 1 | -1 | 2 | 0 | 3 | 1 | 1 | 1 | 1 | -1 |
| Operating Profit Margin % | 10.00% | -9.00% | 2.00% | 0.00% | 0.00% | 4.00% | -4.00% | -1.00% | -2.00% | 6.00% | -3.00% | 8.00% | 9.00% | 15.00% | 0.00% | 3.00% | 2.00% | 8.00% | 8.00% | 4.00% | 5.00% | -12.00% | 7.00% | -2.00% | 2.00% | 3.00% | 7.00% | 4.00% | 4.00% | -7.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | -4 | -1 | -1 | -1 | 0 | -2 | -1 | -2 | 1 | -1 | 1 | 1 | 2 | -1 | 0 | 1 | 0 | 1 | 0 | 0 | -2 | 0 | -1 | 1 | -1 | 0 | 0 | 0 | -2 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | -4 | -1 | -1 | -1 | 0 | -2 | -1 | -2 | 1 | -1 | 1 | 1 | 2 | -1 | 0 | 1 | 0 | 1 | 0 | 0 | -2 | 0 | -1 | 2 | -1 | 0 | 0 | 0 | -2 |
| Earnings Per Share (₹) | 3.17 | -7.03 | -2.02 | -2.41 | -1.81 | -0.50 | -4.03 | -2.32 | -3.80 | 1.04 | -2.48 | 1.68 | 1.29 | 3.84 | -2.05 | -0.67 | 2.23 | 0.27 | 1.63 | -0.50 | -0.66 | -3.68 | 0.16 | -2.59 | 2.96 | -1.55 | 0.01 | -0.56 | -1.16 | -4.46 |
Related Pages for GKB Ophthalmics
Additional stock information and data for GKB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 125 | 115 | 112 | 110 | 107 | 102 | 93 | 83 | 82 | 69 | 75 |
| Current Assets | 99 | 88 | 84 | 76 | 74 | 73 | 64 | 64 | 63 | 51 | 46 |
| Fixed Assets | 17 | 18 | 19 | 23 | 24 | 26 | 26 | 18 | 18 | 13 | 12 |
| Capital Work in Progress | 4 | 4 | 4 | 3 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
| Investments | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 4 | 6 | 0 |
| Other Assets | 102 | 91 | 87 | 82 | 80 | 75 | 67 | 64 | 60 | 50 | 63 |
| LIABILITIES | |||||||||||
| Total Liabilities | 125 | 115 | 112 | 110 | 107 | 102 | 93 | 83 | 82 | 69 | 75 |
| Current Liabilities | 6 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 56 | 64 | 67 | 67 | 66 | 59 | 55 | 45 | 47 | 45 | 40 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 47 | 55 | 58 | 58 | 58 | 54 | 47 | 41 | 43 | 41 | 36 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -3 | 4 | -3 | 5 | 7 | 3 | 4 | -3 | -3 | -11 | 7 |
| Investing Activities | 3 | -2 | 1 | -4 | -17 | -4 | -10 | 1 | 4 | 15 | -1 |
| Financing Activities | 1 | -2 | -2 | -2 | 3 | 4 | 13 | 1 | -1 | -3 | -6 |
| Net Cash Flow | 0 | 1 | -4 | 0 | -7 | 4 | 7 | 0 | -1 | 0 | 1 |